Navigation Links
Dr. Mark Popovsky Receives Prominent Award for Leadership in Transfusion Medicine
Date:10/26/2009

BRAINTREE, Mass., Oct. 26 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) announced today that Dr. Mark Popovsky, Vice President and Chief Medical Officer, has been awarded the Emily Cooley Memorial Award and Lectureship by AABB. The Memorial Award was founded as a lectureship in 1963 and is given annually to a person who has demonstrated teaching ability and made a major contribution to the fields of immunohematology, transfusion medicine, and cellular therapies.

"The Emily Cooley Memorial Award and Lectureship is an excellent recognition of Dr. Popovsky's dedication to and impact on the transfusion industry. We are honored to have Dr. Popovsky as part of our team and congratulate him on this award," said Brian Concannon, President and CEO of Haemonetics.

Dr. Popovsky joined Haemonetics in 2000 as Corporate Medical Director and President of the Cell Processing Division. In addition to his work at Haemonetics, he is currently an Associate Clinical Professor of Pathology at Harvard Medical School and Beth Israel Deaconess Medical Center. Dr. Popovsky currently serves on the editorial board of 5 journals. He has authored, or co-authored, over 375 publications in transfusion medicine and pathology. He is editor and co-editor of two reference books in transfusion medicine. In 2004, he served in Nigeria as a member of the U.S. President's Emergency Plan for AIDS Relief delegation to that country.

Prior to Haemonetics, Dr. Popovsky was with the American Red Cross, New England Region, where he held the positions of Medical Director and then Chief Executive Officer. He also served as Director of the Transfusion and Intravenous Services at the Mayo Clinic. Dr. Popovsky is an honors graduate of the University of Vermont, College of Medicine.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

    Contact:
    Julie Fallon
    Tel. (781) 356-9517
    Alt. Tel. (617) 320-2401

SOURCE Haemonetics Corporation


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmalink AB Receives Patent for Nefecon(R) Principle
2. Solos Endoscopy, Inc. Receives Additional Purchase Orders from National Cancer Institute and National Institute of Health for its MammoView(TM) Product Line
3. Ikaria Receives Award for Excellence by New Jersey Business & Industry Association
4. NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs
5. Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma
6. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
7. Solos Endoscopy, Inc. Receives Multiple Purchase Orders for its MammoView(TM) Product Line
8. WorldHeart Receives IRB Approval at First Center in the Levacor(TM) VAD BTT Clinical Trial
9. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
10. AbbeyMoor Medical Receives Category I CPT(R) Code for The Spanner(TM) Prostatic Stent Procedure
11. Ortho Clinical Diagnostics Receives FDA Approval for First Anti-HIV 1+2 Test for Use on Random Access, Integrated Laboratory Testing System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 8, 2016 Vestagen Technical Textiles, Inc., a ... for healthcare and other demanding applications, today announced it ... He replaces Dale Pfost , PhD, who was ... is also joining Vestagen,s Board of Directors. ... active barrier technologies that combines fluid repellent, antimicrobial and ...
(Date:2/8/2016)... 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... delivery systems, today announced that it will release its financial ... 2015 after market close on February 9, 2016.  At this ... discuss these financial results.    About Unilife Corporation ... About Unilife Corporation UNIS ...
(Date:2/8/2016)... Feb. 8, 2016  Astellas Pharma Inc. President and Chief ... of James Robinson as president, Americas Operations, for ... North and South America , effective April ... representing the commercial organization in the United States ... Masao Yoshida , who is retiring in June ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... ... man who has struggled to quit smoking, a man who has struggled with hair loss ... to his problems – and he did. Now Nabat, a serial entrepreneur featured as the ... inventions to the world and better people's lives. His own experience with nicotine addiction led ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... metro area, has selected the latest beneficiary of their ongoing community enrichment program. ... preventing bullying in area schools. Donations are now being accepted at: http://www.angelsanddoves.com/donate.html ...
(Date:2/8/2016)... ... 08, 2016 , ... Eating disorders and post-traumatic stress disorder ... and men with eating disorders report a history of trauma, research suggests that ... an eating disorder. , At the 2016 iaedp Symposium, the workshop, “What ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com recently ... in Mole removal products. , Moles are derived from a cluster of melanin when ... all the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
(Date:2/7/2016)... Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... correct pelvic organ prolapse with the latest techniques and the most minimally invasive ... for pelvic organ prolapse, particularly after menopause. Other risk factors include surgery to ...
Breaking Medicine News(10 mins):